Which statement best describes the management for intermittent claudication?

• A. Tobacco cessation alone is sufficient
• B. Managing HTN, DM, and lipids alone is sufficient
• C. Anti-platelet therapy alone is sufficient
• D. A combination of tobacco cessation, risk factor management, and antiplatelet therapy is recommended

Answer: (D)

Managing intermittent claudication requires a comprehensive approach that reduces overall cardiovascular risk while addressing symptoms. Stopping tobacco use is essential because smoking accelerates atherosclerosis and worsens limb ischemia. Aggressive control of risk factors—blood pressure, diabetes, and lipids—lowers the risk of cardiovascular events and slows disease progression. Antiplatelet therapy further reduces the likelihood of heart attack and stroke in people with peripheral artery disease. When these strategies are combined, you tackle the disease from multiple angles, providing the best overall protection and symptom management. Relying on any single measure—smoking cessation alone, risk-factor management alone, or antiplatelet therapy alone—leaves other important factors unaddressed.